NCT05923775 is a NA clinical trial of Impacted third molar surgey in Molar, Third, sponsored by Cihan Topan.

Who is sponsoring NCT05923775?

NCT05923775 is sponsored by Cihan Topan.

What drugs are being tested in NCT05923775?

Interventions in NCT05923775: Impacted third molar surgey.

What condition does NCT05923775 study?

NCT05923775 studies Molar, Third.

Is NCT05923775 still recruiting?

NCT05923775 is currently status unknown. Last updated 7 September 2023.

Last reviewed 2023-09-07 · How we verify

NCT05923775

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pain and Trismus Control in Third Molar Surgery: Ibuprofen, Ketamine, and Their Combination

Status unknown NA Last updated 7 September 2023

What this trial tests

NA trial testing Impacted third molar surgey in Molar, Third in 100 participants. Status unknown.

Timeline

1 March 2023

Primary endpoint
15 September 2023

15 September 2023

Quick facts

Lead sponsor	Cihan Topan
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	100
Start date	1 March 2023
Primary completion	15 September 2023
Estimated completion	15 September 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Impacted third molar surgey

Conditions studied

Molar, Third — all drugs for Molar, Third →

Sponsor

Cihan Topan

Who can join

Adults 18 to 25, any sex, with Molar, Third. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the clinical trial is to compare the efficacy of ibuprofen, ketamine, and their combination in managing postoperative pain and trismus following third molar surgery. The main question it aims to answer is: which is the best way to control pain and trismus after third molar surgery?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Molar, Third

Currently open trials in the same condition.

NCT05924191 — Preventive Effect of Photobiomodulation in the Postoperative Period of Extractions of Retained Lower Third Molars · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05923775 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cihan Topan
Last refreshed: 7 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05923775.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing